Precision medicine has so much potential, feels so in line for some really wild breakthroughs, with its ability to make so many exact & small operations.
I wonder where the Obama Precision Medicine (2015) work has gotten to so far. https://obamawhitehouse.archives.gov/the-press-office/2015/0...
The US program has the potential to be even more valuable if managed well, but I haven't seen overwhelming indications of reaching that potential yet; however, I think a few more years are needed for a clear evaluation.
There's now FHIR for sharing records between different vendors' EHR systems. There's a JSONLD representation of FHIR.
Which health and exercise apps can generate FHIR for self-reporting?
Can participants forward their other EHR/EMR records to the All of Us program?
Can participants or Red Cross or other blood donation services forward collected vitals and sample screening data to the All of Us program?
The bigger issue is that clinical imaging is done due to medical indications. Medical indications dramatically confound the results. A key element of the UK Biobank's value is that imaging and ECG are being done without any clinical indication.
SIEM tools do anomaly detection with lots of textual log data and sensor data.
What would a Cost-effectiveness analysis say about collecting data from healthy patients: https://en.wikipedia.org/wiki/Cost-effectiveness_analysis
TIL the ROC curve applies to medical tests.
https://www.massgeneral.org/news/press-release/clinical-tria...
Dr Scolyer is super interesting